Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study

Details 詳細情報について

• CRID

  1360298345421621888

• DOI

  10.1016/s1473-3099(22)00507-2

• ISSN

  14733099

• Web Site

  https://api.elsevier.com/content/article/PII:S1473309922005072?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1473309922005072?httpAccept=text/plain

• Data Source

  • Crossref